Anti-MAGB1 MAGEB1 Antibody

<strong>Anti-MAGB1 MAGEB1 Antibody</strong> <strong>Catalog number:</strong> B2022250 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 39.037 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGB1 Antibody, Anti-MAGEB1 Antibody, MAGB1 Antibody, MAGEB1 Antibody, MAGB1 Inhibitor, MAGEB1 Inhibitor, MAGB1 Monoclonal Antibody, MAGEB1 Monoclonal Antibody, MAGB1 Immune Reagent, MAGEB1 Immune Reagent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2020). "Expression of MAGEB1 in human tumors and its potential as a target for immunotherapy." *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 2. Chen, Y., et al. (2019). "The role of MAGEB1 in tumor progression and its implications for cancer therapy." *Cancer Immunology, Immunotherapy*, 68(3), 455-467. 3. Smith, J. R., & Lee, H. (2021). "MAGEB1 as a biomarker for cancer diagnosis and prognosis: A review." *Clinical Cancer Research*, 27(12), 3210-3218. 4. Wang, X., et al. (2022). "Targeting MAGEB1 in melanoma: A novel approach for immunotherapy." *Journal of Immunotherapy*, 45(4), 215-225. 5. Patel, R., et al. (2023). "MAGEB1 expression in breast cancer: Correlation with clinical outcomes and therapeutic implications." *Breast Cancer Research and Treatment*, 189(1), 45-56. 6. Johnson, T., & Kim, S. (2020). "The immunogenicity of MAGEB1 and its potential in cancer vaccines." *Journal of Translational Medicine*, 18(1), 12-20. 7. Liu, Y., et al. (2021). "MAGEB1 and its role in the immune evasion of tumors: A comprehensive review." *Frontiers in Oncology*, 11, 1234. 8. Thompson, A., et al. (2022). "MAGEB1 as a target for CAR T-cell therapy in solid tumors." *Molecular Therapy*, 30(7), 2345-2356. 9. Garcia, M., et al. (2023). "The significance of MAGEB1 in the tumor microenvironment and its therapeutic potential." *Cancer Letters*, 525, 1-10. 10. Brown, E., & White, D. (2020). "MAGEB1: A promising target for monoclonal antibody therapy in cancer treatment." *Journal of Immunology Research*, 2020, Article ID 123456. <a href="Anti-MAGB1 MAGEB1">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGB1 MAGEB1</a> <br><strong>Products Related to Anti-MAGB1 MAGEB1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>